Sunflower Pharmaceutical Group Co., Ltd.

Sunflower Pharmaceutical Group Co., Ltd. is a prominent Chinese pharmaceutical enterprise listed on the Shenzhen Stock Exchange since 2014. The company specializes in drug development, manufacturing, and sales, producing nearly 300 types of medicines while maintaining a reserve of over 1,100 species. Sunflower's product portfolio primarily includes Chinese patent medicines, chemical and biological medicines, and health care products, covering various therapeutic areas such as children's health, digestive health, gynecology, rheumatology, and cardiovascular health. The company is recognized for its strong branding, particularly in the over-the-counter (OTC) market, with its "Sun Flower" and "Little Sun Flower" brands being well-known in China. Sunflower focuses on children's medicines and geriatrics, aiming to enhance its offerings in these areas through strategic investments in product development and marketing. The company has established a comprehensive marketing network that includes approximately 300,000 retail outlets and nearly 6,000 hospitals across China, enabling efficient distribution of its products.

In the next period of time, company will focus on"the elder and the children". 1. The company’s strategy is focus on the children's medicines. Enhancing the Children's medicinesis risingup to the company’s strategy, and the company will make key investment in the academic promotion, sales policy, resource allocation, andprocudingsuperior varieties. It will focus on creating “goldproducts” of children medicines, such as Children's lung hot cough and asthma oral liquid,Chai Gui fever granule in children, Qi Hu Zha granule, to lead the sales of company’s children medicines. 2. Focus on theelder chronic field and gynecologic medicine Build the company's strengths in the field of geriatric disease, chronic disease, and digestive system drug, and promote the continuous release of the sales of classic old drugs such as liver-protecting tablets, Weikangling, Kangfu anti-inflammatory suppository. At the same time, the company will also work hard onintroducing superior varieties. The company willeffectivelypractice the "craftsman spirit" in the management , carry out the " high quality medicine "project, choose real material and make good medicine for the common people.